Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac gene delivery using DNA-adenoviral constructs.

J Mark Jones1, Walter J Koch

  • 1Department of Cardiac Surgery, Royal Victoria Hospital, Belfast, UK.

Methods in Molecular Medicine
|July 13, 2005
PubMed
Summary

This study presents a novel cardiac gene transfer method using adenoviral vectors during cardiopulmonary bypass. This technique improves gene transfer efficiency and cardiac function post-surgery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

miR-181a post-transcriptionally targets GRK2 to limit maladaptive signaling in cardiomyocytes.

Frontiers in cardiovascular medicine·2026
Same author

Cys340Ser Mutation Abolishing S-Nitrosylation Drives GRK2 Mitochondrial Localization and Dysfunction.

Cells·2026
Same author

GRK2 and GRK5-The 2 critical kinases in cardiac pathophysiology.

Molecular pharmacology·2026
Same author

The denitrosylase SCoR2 controls cardioprotective metabolic reprogramming.

eLife·2025
Same author

Linking phospholipid metabolism to septic cardiomyopathy via HIF-1α overactivation.

Nature cardiovascular research·2025
Same author

Phosphoserine aminotransferase 1 promotes serine synthesis pathway and cardiac repair after myocardial infarction.

Theranostics·2025

Area of Science:

  • Cardiovascular Medicine
  • Gene Therapy
  • Biomedical Engineering

Background:

  • Current cardiac gene transfer methods like direct injection or coronary infusion have limitations.
  • These include short exposure times, potential for injury from high infusion pressures, and extracardiac transgene expression.

Purpose of the Study:

  • To develop a clinically applicable cardiac gene transfer technique overcoming existing limitations.
  • To evaluate the efficacy of adenoviral vector administration during cardioplegic arrest and cardiopulmonary bypass.

Main Methods:

  • Adenoviral vector administered during cardioplegic arrest on cardiopulmonary bypass (CPB).
  • Evaluated prolonged myocardial contact with the vector.
  • Assessed transgene expression in vivo, considering effects of cold and blood contact.

Main Results:

  • Prolonged myocardial contact with the adenoviral vector improved gene transfer.
  • Cold temperatures and blood contact did not negatively impact transgene expression in vivo.
  • Administration of the beta2AR transgene ameliorated cardiac dysfunction post-CPB and cardioplegic arrest.

Conclusions:

  • Adenoviral vector delivery during CPB is a promising cardiac gene transfer strategy.
  • This method allows prolonged myocardial exposure, enhancing gene transfer efficiency.
  • It effectively improves cardiac function following surgical procedures involving CPB and cardioplegic arrest.

Related Experiment Videos